Summary: Resmed says its acquisition of digital-first IDTF VirtuOx supports Resmed’s growth in virtual care, expands access to diagnosis, and enhances the digital experience for patients and providers.
Key Takeaways:
- The acquisition aims to simplify and accelerate the patient journey from initial evaluation to treatment, reducing patient drop-off and improving access to care.
- Resmed’s integration of VirtuOx’s diagnostic capabilities is designed to help healthcare providers and home medical equipment companies coordinate care more effectively, alleviating bottlenecks in the diagnostic process.
- The acquisition supports Resmed’s strategic growth into adjacent healthcare areas such as insomnia management, while deepening partnerships with physicians, sleep labs, and equipment providers.
Resmed has acquired VirtuOx, an independent diagnostic testing facility (IDTF) for sleep, respiratory, and cardiac conditions.
With VirtuOx’s at-home diagnostic services, Resmed will be better positioned to support patients earlier in their journey and help healthcare providers and homecare companies deliver care in a more connected way. According to Resmed, the acquisition reflects the company’s commitment to improving the way care is delivered—by making it more accessible, coordinated, and patient-friendly.
VirtuOx’s virtual testing platform offers flexible options for patients, boosting a digital-first experience that can make the difference between following through on testing and treatment—or falling out of the care pathway entirely.
“This is about creating a simpler, more connected pathway to care,” says Justin Leong, chief product officer at Resmed, in a release. “By integrating VirtuOx’s diagnostic capabilities into our ecosystem, we can help accelerate the time between evaluation and treatment, reduce drop-off, and help more people access the life-changing benefits of therapy for sleep apnea and related conditions.”
According to Resmed, this acquisition strengthens Resmed’s ability to partner with healthcare providers to help streamline the diagnostic process and alleviate current bottlenecks, while expanding collaboration with home medical equipment providers to efficiently and expeditiously support patients to start treatment. It further enhances the company’s ability to serve healthcare providers with integrated tools that improve care coordination, patient engagement, and outcomes.
“VirtuOx and Resmed are aligned in our focus to simplify healthcare and expand access,” says Steve Lica, CEO of VirtuOx, in a release. “Joining Resmed gives us the opportunity to scale our impact, reach, and help more patients, and keep innovating on behalf of the providers and health systems we serve.”
The acquisition supports a growing demand for home-based care—driven by increased awareness, convenience, and digital innovation. It also creates opportunities to expand into adjacent areas such as insomnia, while deepening Resmed’s relationships with physicians, sleep labs, and home medical equipment providers.
VirtuOx will operate as a fully owned subsidiary of Resmed following the transaction, continuing to serve partners and patients under its existing brand in the near term. The VirtuOx leadership team will remain in place and continue to drive the company’s growth and innovation strategy.
Financial terms are not being disclosed, as the acquisition is not material to Resmed’s financial results.
